Article info
PDFLaw, ethics and medicine
Paper
Vulnerability, therapeutic misconception and informed consent: is there a need for special treatment of pregnant women in fetus-regarding clinical trials?
- Correspondence to Dr Maria Kreszentia Sheppard, Department of Law, Queen Mary University London, Mile End Road, London E14NS, UK; maria.sheppard{at}qmul.ac.uk
Citation
Vulnerability, therapeutic misconception and informed consent: is there a need for special treatment of pregnant women in fetus-regarding clinical trials?
Publication history
- Received November 14, 2014
- Revised June 16, 2015
- Accepted October 27, 2015
- First published November 19, 2015.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Vulnerability of pregnant women in clinical research
- Protecting children and young people
- Donor-funded research: permissible, not perfect
- Not so new directions in the law of consent? Examining Montgomery v Lanarkshire Health Board
- GMC confidentiality guidance 2017
- The relationship between medical law and good medical ethics
- Patient confidentiality and autonomy: how do we account for coercive control?
- Uterus transplantation: ethical and regulatory challenges
- Confidence, consent and chaperones for pubertal staging examinations: a national survey
- Diagnosis and management of covid-19 in pregnancy